Waters Corporation reported $4.64B of revenue over the trailing twelve months, +52% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $4.64B (to Q2 2026). Net income: $166M, trailing twelve months to Q2 2026. Free cash flow: $395M, trailing twelve months to Q2 2026. Operating margin: 11%, trailing twelve months to Q2 2026.

WATWaters Corporation

Healthcare

$433.70+42% 1Y

$433.70

$283.3252 weeks$443.32

WAT as reported

Waters Corporation reported $4.64B of revenue over the trailing twelve months, +52% on the year before. 11 reported series are charted on this page, each one as filed.

$4.64B

Revenue, trailing twelve months · to Q2 2026 · +52% against the twelve months before

Net income: $166M
Net income · −75% year on year · trailing twelve months to Q2 2026
Free cash flow: $395M
Free cash flow · −36% year on year · trailing twelve months to Q2 2026
Operating margin: 11%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for WAT, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$4.64B	+52%	Q2 2026
Net income	$166M	−75%	Q2 2026
EPS	$4.01	−64%	Q2 2026
Gross margin	59%	n/a	Q4 2025
Operating margin	11%	n/a	Q2 2026
Net margin	7.2%	n/a	Q2 2026
ROE	14%	n/a	Q2 2026
ROA	7.1%	n/a	Q2 2026
ROIC	11%	n/a	Q2 2026
Free cash flow	$395M	−36%	Q2 2026
P/E	108	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.